Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Trending Topics Diabetes Fierce 50 Special Report Awards Gala Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Subscribe Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Trending Topics Diabetes Fierce 50 Special Report Awards Gala Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Stories Sponsored Artificial Intelligence in Drug Discovery Requires Validated Data Fronts Teaser Discover how BioIVT ensures data from over 1 million biospecimens is ready for AI drug and diagnostic development workflows. Sponsored by BioIVT Sponsored NAFLD & NASH: Emerging In Vitro Models Aid Drug Discovery Fronts Teaser New models may help in developing specialized therapeutics for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Sponsored by BioIVT Sponsored Why Ethical Procurement Matters for Human Biospecimens Fronts Teaser As Scientists Face Pressure to Quickly Develop Novel Therapeutics, Collecting Specimens Ethically Remains Critical Sponsored by BioIVT Sponsored Kupffer Cells in Complex In Vitro Cultures: An Important Tool For Drug Discovery Fronts Teaser The inclusion of Kupffer cells in in vitro hepatic cultures provides researchers with advanced tools for disease modeling and drug discovery. Sponsored by BioIVT
Sponsored Artificial Intelligence in Drug Discovery Requires Validated Data Fronts Teaser Discover how BioIVT ensures data from over 1 million biospecimens is ready for AI drug and diagnostic development workflows. Sponsored by BioIVT
Sponsored NAFLD & NASH: Emerging In Vitro Models Aid Drug Discovery Fronts Teaser New models may help in developing specialized therapeutics for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Sponsored by BioIVT
Sponsored Why Ethical Procurement Matters for Human Biospecimens Fronts Teaser As Scientists Face Pressure to Quickly Develop Novel Therapeutics, Collecting Specimens Ethically Remains Critical Sponsored by BioIVT
Sponsored Kupffer Cells in Complex In Vitro Cultures: An Important Tool For Drug Discovery Fronts Teaser The inclusion of Kupffer cells in in vitro hepatic cultures provides researchers with advanced tools for disease modeling and drug discovery. Sponsored by BioIVT